β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites May 6, 2011
Composition, Standardization and Chemical Profiling of Banisteriopsis caapi, a Plant for the Treatment of Neurodegenerative Disorders Relevant to Parkinson’s Disease April 21, 2010
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series March 26, 2010
Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease October 30, 2009
Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK January 29, 2009
Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness January 1, 1999
